Latest in October’s Sales
Sort by
486 items
-
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.Business - MarketWatch - October 30 -
Prada continues to defy luxury slowdown as Miu Miu sales boom
Italian group bucks gloom but warns that conditions in Asia are becoming ‘more challenging’Business - Financial Times - October 30 -
EBay’s sales outlook comes in weaker, and stock falls more than 7%
EBay’s slightly better-than-expected quarterly earnings were no match for a weaker sales outlook.Business - MarketWatch - October 31